---

Are Microfilariae of Wuchereria bancrofti Larvae?

---

What Are Microfilariae?

• The gravid female produces large numbers of embryonated eggs
• At oviposition (egg laying), the embryo uncoils to its full length (200-300 µm) inside the egg shell
• The egg shell elongates and is retained as a thin, flexible sheath
• This sheathed embryo is what we call a microfilaria ("small thread")

---

The Distinction: Embryo vs. Larva

---

Life Cycle Context

1. L1 larva - microfilaria develops after being ingested by mosquito
2. L2 larva - first molt inside mosquito flight muscles
3. L3 larva (infective stage) - migrates to mosquito's proboscis; this is the true infective larva that enters a new human host during a blood meal

---

Characteristics of W. bancrofti Microfilariae

---

Why the Confusion?

• Microfilariae are pre-larval - they have not yet undergone any larval molt
• The true L1 stage only begins inside the mosquito after the microfilaria is ingested
• The term "larva" is more correctly reserved for post-embryonic, post-molt stages in the mosquito

---

---

Wuchereria bancrofti - Complete Microbiology

---

1. Classification

---

2. Morphology

Adult Worms

• Long, slender, thread-like white worms coiled in lymphatic vessels
• Female: ~100 mm (10 cm) long
• Male: ~40 mm long
• Adults live coiled together in lymphatic vessels for up to 10 years
• Both sexes harbor endosymbiotic Wolbachia bacteria in their gut, which are required for normal reproduction and metabolism

Microfilariae

---

3. Life Cycle

In the Human Host

1. Infected mosquito bites → deposits L3 (infective) larvae into the skin wound
2. L3 larvae migrate to the lymphatic vessels (arms, legs, groin)
3. Larvae undergo molts and mature into adult worms over 6-12 months
4. Adults mate; gravid females produce microfilariae → microfilariae enter lymph → reach peripheral blood
5. Adults persist for up to 10 years

In the Mosquito (Intermediate Host/Vector)

1. Mosquito ingests microfilariae during a blood meal
2. Microfilariae shed their sheath and penetrate the mosquito stomach wall
3. Develop in thoracic flight muscles: microfilaria → L1 (rhabditiform) → L2 → L3 (filariform/infective)
4. L3 larvae migrate to the proboscis (mouthparts)
5. Transmitted to a new human host during the next blood meal

Vector Mosquitoes

• W. bancrofti: transmitted by Culex, Anopheles, and Aedes mosquitoes
• No animal reservoir for W. bancrofti (humans are the only definitive host)

---

4. Epidemiology

• Infects approximately 120 million people in 73 countries
• Endemic in: central Africa, Mediterranean coast, Asia (India, China, Korea, Japan, Philippines, Malaysia), parts of Caribbean and South America (Haiti, Brazil, Trinidad)
• Concentrated in poorly sanitized, densely crowded urban and tropical/subtropical areas
• B. malayi (related species) has animal reservoirs (cats, monkeys); W. bancrofti does not

---

5. Pathology and Pathogenesis

Mechanism

Acute Phase

• Presence of molting adolescent worms and dying adults triggers:
  • Dilatation of lymphatics
  • Hyperplastic endothelial changes
  • Lymphatic infiltration by lymphocytes, plasma cells, and eosinophils
  • Thrombus formation (acute lymphangitis)
• Granuloma formation and fibrosis follow
• Recurring acute episodes of fever, lymphadenitis, lymphangitis, chills

Chronic Phase

• Repeated infections → permanent lymphatic obstruction
• Lymphedema, ascites, pleural effusion, hydrocele, joint effusion
• Elephantiasis: grotesque enlargement of extremities, scrotum, breasts from massive lymphatic blockade + skin thickening/fibrosis
• Dilated lymphatics may rupture → abscess, draining sinuses, chyluria (lymph in urine)
• Bacterial and fungal superinfections worsen tissue damage

Tropical Pulmonary Eosinophilia (TPE)

• Rare syndrome (< 1% of infected)
• Immune hyperresponsiveness to microfilariae trapped in the lungs
• Features: nocturnal paroxysmal cough/wheezing, weight loss, low-grade fever, marked blood eosinophilia (≥3000/µL), elevated IgE
• More common in young adult males
• Microfilariae usually absent from blood in TPE
• Responds rapidly to DEC

---

6. Clinical Syndromes

---

7. Laboratory Diagnosis

Direct Detection

Indirect / Molecular

Species Differentiation of Microfilariae

• W. bancrofti: sheathed, tail nuclei absent, sheath does not stain pink with Giemsa
• B. malayi: sheathed, 2 distinct nuclei in tail, sheath stains bright pink with Giemsa

---

8. Treatment

Drug of Choice

• Mechanism: stimulates cholinergic receptors → muscle depolarization → worm paralysis; also enhances leukocyte adherence to microfilariae
• Kills microfilariae primarily; also has activity against adult worms
• Caution: Destruction of microfilariae releases Wolbachia antigens → inflammatory reaction (Mazzotti-like reaction); always screen for co-infection with Loa loa (risk of encephalopathy) and Onchocerca volvulus before starting DEC

Alternative/Adjunct Drugs

Mass Drug Administration (MDA)

---

9. Prevention and Control

• Vector control: insecticide spraying, larval source reduction (Culex breeding sites)
• Personal protection: mosquito nets, repellents, protective clothing
• Mass drug administration (MDA): annual single-dose treatment of entire at-risk populations
• No animal reservoir for W. bancrofti - human-to-mosquito-to-human transmission only

---

10. Key Distinguishing Facts (High-Yield Summary)

---